Glaucoma Therapeutics Market

Glaucoma Therapeutics Market: Global Industry Analysis 2012 - 2016 and Opportunity Assessment; 2017 - 2027

  • Ongoing
  • September 2020
  • REP-GB-6456
  • Format: PDF/PPT/Excel

  • US$5,000
  • US$7,500
  • US$10,000

This Glaucoma Therapeutics market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Glaucoma Therapeutics market.

Glaucoma is the eye disease that damage the patient eye nerve optics. The formation extra fluid up in the front part of the eye results the damage to eye nerve optics. Glaucoma is of two type, primary open-angle glaucoma and angle-closure glaucoma which is also referred as closed-angle glaucoma or narrow-angle glaucoma. Open-angle glaucoma is the most common type glaucoma. Primary glaucoma gradually happens when the eye does not drain the fluids. This result the building of pressure on eye nerve optics. Open glaucoma causes no change in the eye vision and it is painless too. Closed-angle glaucoma happens very close to the drainage angle which results the blocking of drainage angle of eyesight. This is a very acute type of glaucoma.  This type of glaucoma may affect the vision of the patient and it may cause severe pain to the eye and the headache.  Glaucoma is generally treated with eye drops, pill, traditional surgery, laser surgery and sometimes the combination of these methods. The aim of glaucoma treatment is to avoid the vision loss of patient wherever if the vision of particular patient is already lost then it is irreversible by glaucoma treatment. Regular consumption of medication as prescribed by the physician is very necessary for the proper treatment of glaucoma.  The drugs of glaucoma have very fewer chances of effects which has increased it adoption the global market.

  • Identify Key Market Forces and their Long-Term Forecast
  • Sneak Peek into Key Forecast Factors and thier Impact

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Glaucoma Therapeutics Market: Drivers and Restraints

The change in the lifestyle of people has resulted in the rise in the prevalence of glaucoma globally. Increasing prevalence of glaucoma is the primary factor driving the growth of glaucoma therapeutics market around the globe. Glaucoma is more prevalent among the people above the age of 60. Rising geriatric population thought the globe is also responsible for the robust growth of glaucoma therapeutics market over the forecast period. Increasing preference of physician towards the laser surgery for the treatment of glaucoma will propel the growth of glaucoma therapeutics market over the forecast period. Less awareness among the people about the glaucoma treatment will deter the growth of glaucoma therapeutics market to some extent. Moreover, lack of availability of skilled professional for laser surgery in under developing economies will also hamper the growth of glaucoma therapeutics market.

Glaucoma Therapeutics Market: Overview

Glaucoma Therapeutics market is expected show exponential growth over the forecast period due to increasing prevalence of glaucoma throughout the globe. According to the journal published at NCBI, glaucoma is the leading cause of blindness among the people worldwide. By treatment type, medication eye drops segment will hold the maximum market share for the global glaucoma therapeutic market due to its high preference by the physician for medication during the early stages of treatment. Laser surgery is more preferred than tradition surgery by booth surgeon and the patients owing to the low risk of failure. By glaucoma type, closed glaucoma will dominate the maximum market share attributed to its more prevalence then open glaucoma.

Glaucoma Therapeutics Market: Regional Overview

Based on geographic region Glaucoma Therapeutics market is classified into seven key regions, North, America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, Middle East and Africa. North America is expected to dominate the glaucoma therapeutics market owing to high healthcare infrastructure. Western Europe and APEJ then follow North America glaucoma therapeutics market. The favorable reimbursement scenario is responsible for the high growth of glaucoma therapeutics market in Western Europe. APEJ region has also shown the substantial growth for glaucoma therapeutics market due rise geriatric population. In APEJ region China and India are expected to be the major market for glaucoma therapeutics over the forecast period. Latin America and Middle East and Africa is the least lucrative market for glaucoma therapeutics due to less awareness among the patient about the glaucoma.    

Glaucoma Therapeutics Market: Key Players

Some of player across the value chain of Glaucoma Therapeutics market are Novartis AG, Allergan, Merck & Co., Inc., Akorn, Inc., Bausch & Lomb Incorporated, Teva Pharmaceuticals, Pfizer and Santen and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Glaucoma Therapeutics Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Glaucoma Therapeutics Market: Segmentation

The global Glaucoma Therapeutics market is classified on the basis of treatment type, glaucoma type, and geographic region.

Based on treatment type, Glaucoma Therapeutics market is segmented into following:

  • Eye Drops
  • Medication
  • Laser Surgery
  • Traditional Surgery

Based on glaucoma type, Glaucoma Therapeutics market is segmented into following:

  • Open-angle glaucoma
  • Closed-angle glaucoma

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Glaucoma Therapeutics Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Glaucoma Therapeutics Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch

Harish Tiwari

Global Head - Business Development

Akshay Godge

Client Partner - Global Business Development

Our Clients

Request Sample Request customization Request Methodology